Huw Nash
InvestorVenture Partner at Scion Life Sciences · Executive at Stoke Therapeutics
Lexington, Massachusetts, United States
Find your path to Huw
524 people in our graph share verified history with Huw — schools, employers, funds. One of them is your warm intro.
Adam ValkinunlockedHuw: together at Harvard University (1992–1996)
×11Huw: together at Harvard University
About
Huw Nash is a Venture Partner at Scion with over 27 years of experience founding, funding, and leading biotechnology start-ups. He was the founding CEO and later COO and CBO of Stoke Therapeutics, and previously an Entrepreneur-in-Residence at Apple Tree Partners. Earlier he co-founded Aileron Therapeutics and was a founding scientist of NeoGenesis Pharmaceuticals, which was acquired by Schering-Plough in 2005. He holds a B.A. in Biochemical Sciences from Harvard College and a Ph.D. in Organic Chemistry from Harvard University.
Invests in
Biotech
Executive at Stoke Therapeutics
Intro paths
→
In turn, Huw can intro founders to Stoke Therapeutics's investors below.
Stoke Therapeutics's investors · 2
Co-founders at Stoke Therapeutics
AK
Adrian KrainerExecutive Officer, Director, Promoter
IA
Isabel AznarezExecutive Officer, Director, Promoter
Experience
- Scion Life SciencesVenture Partnercurrent2024 — presentBoston, Massachusetts, United States
- Stoke TherapeuticsChief Operating Officer & Chief Business Officer2017 — 2024Greater Boston
- Stoke TherapeuticsChief Executive Officer2014 — 2017Greater Boston
- Apple Tree PartnersEntrepreneur in Residence2014 — 2017New York City Metropolitan Area
- Wyss Institute for Biologically Inspired EngineeringEntrepreneur in Residence2014Greater Boston
- Novartis Venture FundConsultant2013 — 2014Cambridge, MA
- Aileron TherapeuticsCo-Founder and Vice President, Corporate Development2005 — 2013Cambridge, MA
- NeoGenesis PharmaceuticalsFounding Scientist and Vice President, External Collaborations1997 — 2005Cambridge, MA
Skills & more
InventorEarly Stage InvestmentStart-up VenturesVenture ManagementStart-ups18Biotechnology19Entrepreneurship17Venture Financing5Business Development8Team BuildingIn-licensing1Intellectual Property14
+11 more
Global Alliance ManagementPharmaceutical IndustryChemistryPatentsClinical DevelopmentR&DDrug DiscoveryTechnology TransferLife SciencesDrug DevelopmentStrategyFrom Huw's professional profile.
Colleagues at Scion Life Sciences
Aaron Kantoff
Managing Partner at Scion Life Sciences
Andreas Loew
Partner at Scion Life Sciences
Dave Katona
Head of Business Development & Investor Relations at Scion Life Sciences
Elliot Warner
Associate at Scion Life Sciences
Jeffrey Edelman
Partner at Scion Life Sciences
Lalo Flores
Venture Partner at Scion Life Sciences
Megan Blewett
Principal at Scion Life Sciences
Romesh Subramanian
Venture Partner at Scion Life Sciences
Frequently asked questions
- Who is Huw Nash?
- Huw Nash is a Venture Partner at Scion with over 27 years of experience founding, funding, and leading biotechnology start-ups. He was the founding CEO and later COO and CBO of Stoke Therapeutics, and previously an Entrepreneur-in-Residence at Apple Tree Partners. Earlier he co-founded Aileron Therapeutics and was a founding scientist of NeoGenesis Pharmaceuticals, which was acquired by Schering-Plough in 2005. He holds a B.A. in Biochemical Sciences from Harvard College and a Ph.D. in Organic Chemistry from Harvard University.
- Where does Huw Nash work?
- Huw Nash is Venture Partner at Scion Life Sciences and Executive at Stoke Therapeutics.
- What does Huw Nash invest in?
- Huw Nash invests in Biotech.
- Where did Huw Nash go to school?
- Huw Nash studied at Harvard University (Doctor of Philosophy (Ph.D.), Organic Chemistry); Harvard University (Bachelor of Arts (B.A.), Biochemistry).
Founder mafias
Scion Life Sciences mafia6
Also came through, then founded or led a company.
Novartis Venture Fund mafia2
Also came through, then founded or led a company.
Same school
Also attended Harvard University2,000
Ron ConwayFounder of SV AngelAlfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalG
+ 1,994 more
Shared employers
Also worked at Stoke Therapeutics5
Also worked at Apple Tree Partners11
Victor RusuPrincipal at MPM BioImpactJernej GodecPrincipal at Atlas VentureSamuel HallManaging Partner at Scion Life SciencesAaron KantoffManaging Partner at Scion Life SciencesAndreas LoewPartner at Scion Life SciencesChristine BorowskiVice President at Access Biotechnology
+ 5 more
Also worked at Wyss Institute for Biologically Inspired Engineering49
David KoleskyPrincipal at MPM BioImpactDr Jonathan AvesarScientific Lead at Lever VCJustin FengSenior Associate at Atlas VentureLaura BrassManaging Director at the Novartis Venture FundHelen WangChief AI and Data Science Officer at Apex GroupAishu SukumarAlzheimer's Moonshot Impact Board at StartUp Health
+ 43 more
Also worked at Novartis Venture Fund332
Rebecca JamesInvestor at Index VenturesScott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock Ventures
+ 326 more